SENSULIN
Sensulin, LLC is developing a true once-a-day glucose-responsive insulin, that may mimic a healthy human pancreas. Sensulin may eliminate the need for basal & prandial insulin, offer a substantial improvement in the standard of care, and most importantly, give those with diabetes a chance at a normal life.
SENSULIN
Industry:
Biotechnology Diabetes Health Care
Founded:
2011-08-09
Address:
Oklahoma City, Oklahoma, United States
Country:
United States
Website Url:
http://www.sensulin.com
Total Employee:
1+
Status:
Active
Contact:
650-479-6453
Email Addresses:
[email protected]
Total Funding:
3.28 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API IPv6 Google Apps For Business Google Maps Google GStatic Google Static Content
Similar Organizations
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cortado Ventures
Cortado Ventures investment in Series A - Sensulin
AngelMD
AngelMD investment in Series B - Sensulin
Cowboy Technology Angels
Cowboy Technology Angels investment in Angel Round - Sensulin
National Science Foundation
National Science Foundation investment in Grant - Sensulin
MassChallenge
MassChallenge investment in Grant - Sensulin
Official Site Inspections
http://www.sensulin.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
